Stakeholders apply the GRADE evidence-to-decision framework to facilitate coverage decisions.

[1]  Elie A Akl,et al.  GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. , 2016, Journal of clinical epidemiology.

[2]  G. Guyatt,et al.  GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines , 2016, British Medical Journal.

[3]  Gordon H Guyatt,et al.  GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction , 2016, British Medical Journal.

[4]  R. Busse,et al.  Published and unpublished evidence in coverage decision-making for pharmaceuticals in Europe: existing approaches and way forward , 2016, Health Research Policy and Systems.

[5]  Robert B. Doherty.  Goodbye, Sustainable Growth RateHello, Merit-Based Incentive Payment System , 2015, Annals of Internal Medicine.

[6]  Elena Parmelli,et al.  Conceptual frameworks and key dimensions to support coverage decisions for vaccines. , 2015, Vaccine.

[7]  Joshua T. Cohen,et al.  Medicare is scrutinizing evidence more tightly for national coverage determinations. , 2015, Health affairs.

[8]  David Rind,et al.  GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. , 2013, Journal of clinical epidemiology.

[9]  Elie A Akl,et al.  GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. , 2013, Journal of clinical epidemiology.

[10]  Sarah E. Rosenbaum,et al.  Policymakers’ and other stakeholders’ perceptions of key considerations for health system decisions and the presentation of evidence to inform those considerations: an international survey , 2013, Health Research Policy and Systems.

[11]  G. Guyatt,et al.  GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. , 2013, Journal of clinical epidemiology.

[12]  Sarah E. Rosenbaum,et al.  Developing and evaluating communication strategies to support informed decisions and practice based on evidence (DECIDE): protocol and preliminary results , 2013, Implementation Science.

[13]  P. Neumann,et al.  Medicare's enduring struggle to define "reasonable and necessary" care. , 2012, The New England journal of medicine.

[14]  K. Fischer,et al.  A systematic review of coverage decision-making on health technologies-evidence from the real world. , 2012, Health policy.

[15]  Paul Kind,et al.  From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking , 2012, Cost Effectiveness and Resource Allocation.

[16]  G. Guyatt,et al.  Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[17]  P. Neumann,et al.  Listening to Provenge--what a costly cancer treatment says about future Medicare policy. , 2011, The New England journal of medicine.

[18]  G. Guyatt,et al.  GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.

[19]  Sarah E. Rosenbaum,et al.  Evidence summaries tailored to health policy-makers in low- and middle-income countries. , 2011, Bulletin of the World Health Organization.

[20]  Sarah E. Rosenbaum,et al.  Presenting the Results of Cochrane Systematic Reviews to a Consumer Audience: A Qualitative Study , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.

[21]  Xin Sun,et al.  Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses , 2010, BMJ : British Medical Journal.

[22]  Andrew D Oxman,et al.  SUPPORT Tools for evidence-informed health Policymaking (STP) 1: What is evidence-informed policymaking? , 2009, Health Research Policy and Systems.

[23]  Jeremy Grimshaw,et al.  AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. , 2009, Journal of clinical epidemiology.

[24]  G. Guyatt,et al.  Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive , 2008, BMJ : British Medical Journal.

[25]  Gordon H Guyatt,et al.  Incorporating considerations of resources use into grading recommendations , 2008, BMJ : British Medical Journal.

[26]  Gordon H Guyatt,et al.  GRADE: grading quality of evidence and strength of recommendations for diagnostic tests and strategies , 2008, BMJ : British Medical Journal.

[27]  G. Guyatt,et al.  Going from evidence to recommendations , 2008, BMJ : British Medical Journal.

[28]  Gordon H Guyatt,et al.  GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .

[29]  Hsiu-Fang Hsieh,et al.  Three Approaches to Qualitative Content Analysis , 2005, Qualitative health research.

[30]  M. Weinstein,et al.  Medicare and cost-effectiveness analysis. , 2005, The New England journal of medicine.